Find out how Novagraaf assisted the University of Bordeaux and University Medical Centre of Bordeaux’s IP management organisation, SATT Aquitaine Science Transfer, to protect a new breakthrough treatment.
Holders of Patent Cooperation Treaty (PCT) international applications will soon be able to apply for protection of their invention in Italy without going through the European Patent system.
EPO ruling on CRISPR gene-editing patent is only the latest example of priority arrangements made according to US practice causing problems for European Patent applications, as Dr Oliver Harris explains.
Patents, trademarks, designs and other forms of intellectual property (IP) play a key role in the success of all modern businesses.
Regulation (EU) 2019/933 on Supplementary Protection Certificates (SPCs) entered into force on 1 July 2019. It amended Regulation (EC) No 469/2009 on SPCs by introducing a manufacturing waiver for generics and biosimilars within the EU.
Small and medium-sized enterprises (SMEs) that apply for patents, trademarks or designs are more likely to experience high growth than SMEs that do not, according to a joint study by the EPO and the EUIPO.
Advance preparation is crucial for any transfer of IP ownership. Yet, no matter how extensive the IP due diligence before a merger or acquisition deal is agreed, the recordal process rarely passes without hitch.
The EPO’s Enlarged Board of Appeal is to consider the patentability of computer-implemented inventions in the context of appeal T0489/14, concerning a European patent application to protect a computer simulation invention.
First broadcasted on 13 March 2019, this webinar will explain the status of Brexit negotiations (as of 13 March) and the plans that have been put in place for the cloning of IP rights (including in a ‘no-deal’ scenario).
As is usually the case with IP, it saves time and money over the longer term if a strategy is in place in advance of a brand takeover or launch. The same is true when two businesses merge.
It may be desirable or indeed necessary to retain existing ownership structures for brands acquired as part of a merger or acquisition (M&A). However, if the newly merged business has been rebranded, the conflict between the registered legacy brands and the new brand will need to be resolved.
Not to be confused with the much delayed Unitary Patent, the European Patent system provides companies with an important structure for protecting and exploiting inventions in Europe. However, certain requirements must be met if patent holders are to make best use of the system.